PANTOPRAZOL NOBEL cpr pell 40 mg bte 160 pce

7680676440114 CH-67644 A02BC02 04.99.0.
PANTOPRAZOL NOBEL cpr pell 40 mg bte 160 pce
PANTOPRAZOL NOBEL cpr pell 40 mg bte 160 pce
PANTOPRAZOL NOBEL cpr pell 40 mg bte 160 pce
1 / 3
google

Details

Product number
6764402
CPT
-
Packaging group
160
Unit
Tablette(n)
Composition
pantoprazolum 40 mg ut pantoprazolum natricum sesquihydricum, trinatrii phosphas anhydricus, isomaltum 58.5 mg, carmellosum natricum, crospovidonum, natrii stearylis fumaras, Überzug: hypromellosum, povidonum K 25, propylenglycolum, E 171, E 172, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, triethylis citras, dimeticonum, sorbitani stearas, polysorbatum 60, silica colloidalis anhydrica, xanthani gummi, E 210 < 1.3 µg, E 200, kalii hydroxidum, acidum hydrochloridum, pro compresso obducto corresp. natrium 7.17 mg.

Articles (1)

Pantoprazol NOBEL 40 mg, magensaftresistente Tabletten
Magensaftresistente Tabletten
160
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
22/08/2024
Professional SmPC
Français
22/08/2024
Professional SmPC
Italien
22/08/2024
Patient information leaflet
Allemand
13/07/2023
Patient information leaflet
Français
13/07/2023
Patient information leaflet
Italien
13/07/2023

Detailed composition

Substance Quantity Type Category
(N/A)
40.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
58.5 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
7.17 MG Substance HBESI

Authorization holder

NOBEL Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
67644
Drug name
Pantoprazol NOBEL, magensaftresistente Tabletten
Galenic form
MATB
ATC Code
A02BC02
Authorization status
Z
Dispensation category
B
First authorization
13/09/2019
Authorization expiration date
31/12/9999
IT number
04.99.0.
Domain
Human medicine
Field of application
Ulcustherapie, Refluxoesophagitis, Zollinger-Ellison-Syndrom

Packaging details

Description (FR)
PANTOPRAZOL NOBEL cpr pell 40 mg bte 160 pce
Description (DE)
PANTOPRAZOL NOBEL Filmtabl 40 mg Ds 160 Stk
Market launch
13/09/2019
Narcotic (BTM)
No

Available generics

Panprax, magensaftresistente Tabletten
CHF 14.35
View
Panprax, magensaftresistente Tabletten
CHF 25.85
View
Panprax, magensaftresistente Tabletten
CHF 34.35
View
Panprax, magensaftresistente Tabletten
CHF 45.85
View
Panprax, magensaftresistente Tabletten
CHF 14.15
View
Panprax, magensaftresistente Tabletten
CHF 18.50
View
Panprax, magensaftresistente Tabletten
CHF 34.10
View
Panprax, magensaftresistente Tabletten
CHF 36.05
View
Panprax, magensaftresistente Tabletten
CHF 49.10
View
Pantoprazol axapharm, magensaftresistente Tabletten
CHF 14.10
View

Other packaging sizes

PANTOPRAZOL NOBEL cpr pell 20 mg 15 pce
15 TABL
View
PANTOPRAZOL NOBEL cpr pell 20 mg 30 pce
30 TABL
View
PANTOPRAZOL NOBEL cpr pell 20 mg 60 pce
60 TABL
View
PANTOPRAZOL NOBEL cpr pell 20 mg 120 pce
120 TABL
View
PANTOPRAZOL NOBEL cpr pell 20 mg bte 290 pce
290 TABL
View
PANTOPRAZOL NOBEL cpr pell 40 mg 7 pce
7 TABL
View
PANTOPRAZOL NOBEL cpr pell 40 mg 15 pce
15 TABL
View
PANTOPRAZOL NOBEL cpr pell 40 mg 30 pce
30 TABL
View
PANTOPRAZOL NOBEL cpr pell 40 mg 60 pce
60 TABL
View
PANTOPRAZOL NOBEL cpr pell 40 mg 105 pce
105 TABL
View